Foot and Mouth Disease (FMD) Vaccines Industry Research Report 2024
Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.
According to APO Research, the global Foot and Mouth Disease (FMD) Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.
Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.
In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Foot and Mouth Disease (FMD) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Foot and Mouth Disease (FMD) Vaccines.
The report will help the Foot and Mouth Disease (FMD) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Foot and Mouth Disease (FMD) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Foot and Mouth Disease (FMD) Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Foot and Mouth Disease (FMD) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Foot and Mouth Disease (FMD) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Foot and Mouth Disease (FMD) Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Foot and Mouth Disease (FMD) Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Foot and Mouth Disease (FMD) Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Foot and Mouth Disease (FMD) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Foot and Mouth Disease (FMD) Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.
Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.
In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Foot and Mouth Disease (FMD) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Foot and Mouth Disease (FMD) Vaccines.
The report will help the Foot and Mouth Disease (FMD) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Foot and Mouth Disease (FMD) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Foot and Mouth Disease (FMD) Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Jinyu Group
- Cavet Bio
- Indian Immunologicals
- Tecon Group
- CAHIC
- Shen Lian
- Biogenesis Bagу
- BIGVET Biotech
- Boehringer Ingelheim
- MSD Animal Health
- CEVA
- FGBI
- Bayer HealthCare
- Brilliant Bio Pharma
- VECOL
- Sanofi (Merial)
- VETAL
- BVI
- LIMOR
- ME VAC
- Agrovet
- Emergency Vaccines
- Conventional Vaccines
- Cattle
- Pig
- Sheep and Goat
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Foot and Mouth Disease (FMD) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Foot and Mouth Disease (FMD) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Foot and Mouth Disease (FMD) Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Foot and Mouth Disease (FMD) Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Foot and Mouth Disease (FMD) Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Foot and Mouth Disease (FMD) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size (2019-2030) & (US$ Million)
2.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales (2019-2030)
2.2.3 Global Foot and Mouth Disease (FMD) Vaccines Market Average Price (2019-2030)
2.3 Foot and Mouth Disease (FMD) Vaccines by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Emergency Vaccines
2.3.3 Conventional Vaccines
2.4 Foot and Mouth Disease (FMD) Vaccines by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Cattle
2.4.3 Pig
2.4.4 Sheep and Goat
2.4.5 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Foot and Mouth Disease (FMD) Vaccines Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue of Manufacturers (2019-2024)
3.4 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Manufacturers (2019-2024)
3.5 Global Foot and Mouth Disease (FMD) Vaccines Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Product Type & Application
3.8 Global Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Date of Enter into This Industry
3.9 Global Foot and Mouth Disease (FMD) Vaccines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Jinyu Group
4.1.1 Jinyu Group Company Information
4.1.2 Jinyu Group Business Overview
4.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.1.5 Jinyu Group Recent Developments
4.2 Cavet Bio
4.2.1 Cavet Bio Company Information
4.2.2 Cavet Bio Business Overview
4.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.2.5 Cavet Bio Recent Developments
4.3 Indian Immunologicals
4.3.1 Indian Immunologicals Company Information
4.3.2 Indian Immunologicals Business Overview
4.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.3.5 Indian Immunologicals Recent Developments
4.4 Tecon Group
4.4.1 Tecon Group Company Information
4.4.2 Tecon Group Business Overview
4.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.4.5 Tecon Group Recent Developments
4.5 CAHIC
4.5.1 CAHIC Company Information
4.5.2 CAHIC Business Overview
4.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.5.5 CAHIC Recent Developments
4.6 Shen Lian
4.6.1 Shen Lian Company Information
4.6.2 Shen Lian Business Overview
4.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.6.5 Shen Lian Recent Developments
4.7 Biogenesis Bagу
4.7.1 Biogenesis Bagу Company Information
4.7.2 Biogenesis Bagу Business Overview
4.7.3 Biogenesis Bagу Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Biogenesis Bagу Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.7.5 Biogenesis Bagу Recent Developments
4.8 BIGVET Biotech
4.8.1 BIGVET Biotech Company Information
4.8.2 BIGVET Biotech Business Overview
4.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.8.5 BIGVET Biotech Recent Developments
4.9 Boehringer Ingelheim
4.9.1 Boehringer Ingelheim Company Information
4.9.2 Boehringer Ingelheim Business Overview
4.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.9.5 Boehringer Ingelheim Recent Developments
4.10 MSD Animal Health
4.10.1 MSD Animal Health Company Information
4.10.2 MSD Animal Health Business Overview
4.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.10.5 MSD Animal Health Recent Developments
4.11 CEVA
4.11.1 CEVA Company Information
4.11.2 CEVA Business Overview
4.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.11.5 CEVA Recent Developments
4.12 FGBI
4.12.1 FGBI Company Information
4.12.2 FGBI Business Overview
4.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.12.5 FGBI Recent Developments
4.13 Bayer HealthCare
4.13.1 Bayer HealthCare Company Information
4.13.2 Bayer HealthCare Business Overview
4.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.13.5 Bayer HealthCare Recent Developments
4.14 Brilliant Bio Pharma
4.14.1 Brilliant Bio Pharma Company Information
4.14.2 Brilliant Bio Pharma Business Overview
4.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.14.5 Brilliant Bio Pharma Recent Developments
4.15 VECOL
4.15.1 VECOL Company Information
4.15.2 VECOL Business Overview
4.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.15.5 VECOL Recent Developments
4.16 Sanofi (Merial)
4.16.1 Sanofi (Merial) Company Information
4.16.2 Sanofi (Merial) Business Overview
4.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.16.5 Sanofi (Merial) Recent Developments
4.17 VETAL
4.17.1 VETAL Company Information
4.17.2 VETAL Business Overview
4.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.17.5 VETAL Recent Developments
4.18 BVI
4.18.1 BVI Company Information
4.18.2 BVI Business Overview
4.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.18.5 BVI Recent Developments
4.19 LIMOR
4.19.1 LIMOR Company Information
4.19.2 LIMOR Business Overview
4.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.19.5 LIMOR Recent Developments
4.20 ME VAC
4.20.1 ME VAC Company Information
4.20.2 ME VAC Business Overview
4.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.20.5 ME VAC Recent Developments
4.21 Agrovet
4.21.1 Agrovet Company Information
4.21.2 Agrovet Business Overview
4.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.21.5 Agrovet Recent Developments
5 GLOBAL FOOT AND MOUTH DISEASE (FMD) VACCINES MARKET SCENARIO BY REGION
5.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2019-2030
5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2019-2024
5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2025-2030
5.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2019-2030
5.3.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2019-2024
5.3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2025-2030
5.4 North America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
5.4.1 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2019-2030)
5.4.3 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
5.5.1 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2019-2030)
5.5.3 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
5.6.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Country (2019-2030)
5.6.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
5.7.1 Latin America Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2019-2030)
5.7.3 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
5.8.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2019-2030)
5.8.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2019-2030)
6.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2019-2030)
6.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2019-2030)
6.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2019-2030)
6.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2019-2030)
7.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2019-2030)
7.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2019-2030)
7.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2019-2030)
7.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Foot and Mouth Disease (FMD) Vaccines Value Chain Analysis
8.1.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Foot and Mouth Disease (FMD) Vaccines Production Mode & Process
8.2 Foot and Mouth Disease (FMD) Vaccines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Foot and Mouth Disease (FMD) Vaccines Distributors
8.2.3 Foot and Mouth Disease (FMD) Vaccines Customers
9 GLOBAL FOOT AND MOUTH DISEASE (FMD) VACCINES ANALYZING MARKET DYNAMICS
9.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
9.2 Foot and Mouth Disease (FMD) Vaccines Industry Drivers
9.3 Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges
9.4 Foot and Mouth Disease (FMD) Vaccines Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size (2019-2030) & (US$ Million)
2.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales (2019-2030)
2.2.3 Global Foot and Mouth Disease (FMD) Vaccines Market Average Price (2019-2030)
2.3 Foot and Mouth Disease (FMD) Vaccines by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Emergency Vaccines
2.3.3 Conventional Vaccines
2.4 Foot and Mouth Disease (FMD) Vaccines by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Cattle
2.4.3 Pig
2.4.4 Sheep and Goat
2.4.5 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Foot and Mouth Disease (FMD) Vaccines Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue of Manufacturers (2019-2024)
3.4 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Manufacturers (2019-2024)
3.5 Global Foot and Mouth Disease (FMD) Vaccines Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Product Type & Application
3.8 Global Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Date of Enter into This Industry
3.9 Global Foot and Mouth Disease (FMD) Vaccines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Jinyu Group
4.1.1 Jinyu Group Company Information
4.1.2 Jinyu Group Business Overview
4.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.1.5 Jinyu Group Recent Developments
4.2 Cavet Bio
4.2.1 Cavet Bio Company Information
4.2.2 Cavet Bio Business Overview
4.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.2.5 Cavet Bio Recent Developments
4.3 Indian Immunologicals
4.3.1 Indian Immunologicals Company Information
4.3.2 Indian Immunologicals Business Overview
4.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.3.5 Indian Immunologicals Recent Developments
4.4 Tecon Group
4.4.1 Tecon Group Company Information
4.4.2 Tecon Group Business Overview
4.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.4.5 Tecon Group Recent Developments
4.5 CAHIC
4.5.1 CAHIC Company Information
4.5.2 CAHIC Business Overview
4.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.5.5 CAHIC Recent Developments
4.6 Shen Lian
4.6.1 Shen Lian Company Information
4.6.2 Shen Lian Business Overview
4.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.6.5 Shen Lian Recent Developments
4.7 Biogenesis Bagу
4.7.1 Biogenesis Bagу Company Information
4.7.2 Biogenesis Bagу Business Overview
4.7.3 Biogenesis Bagу Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Biogenesis Bagу Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.7.5 Biogenesis Bagу Recent Developments
4.8 BIGVET Biotech
4.8.1 BIGVET Biotech Company Information
4.8.2 BIGVET Biotech Business Overview
4.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.8.5 BIGVET Biotech Recent Developments
4.9 Boehringer Ingelheim
4.9.1 Boehringer Ingelheim Company Information
4.9.2 Boehringer Ingelheim Business Overview
4.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.9.5 Boehringer Ingelheim Recent Developments
4.10 MSD Animal Health
4.10.1 MSD Animal Health Company Information
4.10.2 MSD Animal Health Business Overview
4.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.10.5 MSD Animal Health Recent Developments
4.11 CEVA
4.11.1 CEVA Company Information
4.11.2 CEVA Business Overview
4.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.11.5 CEVA Recent Developments
4.12 FGBI
4.12.1 FGBI Company Information
4.12.2 FGBI Business Overview
4.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.12.5 FGBI Recent Developments
4.13 Bayer HealthCare
4.13.1 Bayer HealthCare Company Information
4.13.2 Bayer HealthCare Business Overview
4.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.13.5 Bayer HealthCare Recent Developments
4.14 Brilliant Bio Pharma
4.14.1 Brilliant Bio Pharma Company Information
4.14.2 Brilliant Bio Pharma Business Overview
4.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.14.5 Brilliant Bio Pharma Recent Developments
4.15 VECOL
4.15.1 VECOL Company Information
4.15.2 VECOL Business Overview
4.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.15.5 VECOL Recent Developments
4.16 Sanofi (Merial)
4.16.1 Sanofi (Merial) Company Information
4.16.2 Sanofi (Merial) Business Overview
4.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.16.5 Sanofi (Merial) Recent Developments
4.17 VETAL
4.17.1 VETAL Company Information
4.17.2 VETAL Business Overview
4.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.17.5 VETAL Recent Developments
4.18 BVI
4.18.1 BVI Company Information
4.18.2 BVI Business Overview
4.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.18.5 BVI Recent Developments
4.19 LIMOR
4.19.1 LIMOR Company Information
4.19.2 LIMOR Business Overview
4.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.19.5 LIMOR Recent Developments
4.20 ME VAC
4.20.1 ME VAC Company Information
4.20.2 ME VAC Business Overview
4.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.20.5 ME VAC Recent Developments
4.21 Agrovet
4.21.1 Agrovet Company Information
4.21.2 Agrovet Business Overview
4.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio
4.21.5 Agrovet Recent Developments
5 GLOBAL FOOT AND MOUTH DISEASE (FMD) VACCINES MARKET SCENARIO BY REGION
5.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2019-2030
5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2019-2024
5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2025-2030
5.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2019-2030
5.3.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2019-2024
5.3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2025-2030
5.4 North America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
5.4.1 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2019-2030)
5.4.3 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
5.5.1 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2019-2030)
5.5.3 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
5.6.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Country (2019-2030)
5.6.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
5.7.1 Latin America Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2019-2030)
5.7.3 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
5.8.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2019-2030)
5.8.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2019-2030)
6.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2019-2030)
6.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2019-2030)
6.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2019-2030)
6.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2019-2030)
7.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2019-2030)
7.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2019-2030)
7.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2019-2030)
7.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Foot and Mouth Disease (FMD) Vaccines Value Chain Analysis
8.1.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Foot and Mouth Disease (FMD) Vaccines Production Mode & Process
8.2 Foot and Mouth Disease (FMD) Vaccines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Foot and Mouth Disease (FMD) Vaccines Distributors
8.2.3 Foot and Mouth Disease (FMD) Vaccines Customers
9 GLOBAL FOOT AND MOUTH DISEASE (FMD) VACCINES ANALYZING MARKET DYNAMICS
9.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
9.2 Foot and Mouth Disease (FMD) Vaccines Industry Drivers
9.3 Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges
9.4 Foot and Mouth Disease (FMD) Vaccines Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
